Literature DB >> 15505412

Apoptosome dysfunction in human cancer.

K M Hajra1, J R Liu.   

Abstract

Apoptosis is a cell suicide mechanism that enables organisms to control cell number and eliminate cells that threaten survival. The apoptotic cascade can be triggered through two major pathways. Extracellular signals such as members of the tumor necrosis factor (TNF) family can activate the receptor-mediated extrinsic pathway. Alternatively, stress signals such as DNA damage, hypoxia, and loss of survival signals may trigger the mitochondrial intrinsic pathway. In the latter, mitochondrial damage results in cytochrome c release and formation of the apoptosome, a multimeric protein complex containing Apaf-1, cytochrome c , and caspase-9. Once bound to the apoptosome, caspase-9 is activated, and subsequently triggers a cascade of effector caspase activation and proteolysis, leading to apoptotic cell death. Recent efforts have led to the identification of multiple factors that modulate apoptosome formation and function. Alterations in the expression and/or function of these factors may contribute to the pathogenesis of cancer and resistance of tumor cells to chemotherapy or radiation. In this review we discuss how disruption of normal apoptosome formation and function may lead or contribute to tumor development and progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505412     DOI: 10.1023/B:APPT.0000045786.98031.1d

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  78 in total

1.  Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells.

Authors:  Lijun Tan; Roland P Kwok; Abhishek Shukla; Malti Kshirsagar; Lili Zhao; Anthony W Opipari; J Rebecca Liu
Journal:  Cancer       Date:  2010-10-05       Impact factor: 6.860

2.  Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.

Authors:  Ying-Xue Wang; Lei Zhao; Xiu-Yun Wang; Chang-Mei Liu; Su-Guo Yu
Journal:  Med Oncol       Date:  2011-11-26       Impact factor: 3.064

3.  Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.

Authors:  Xiefeng Wang; Lili Huang; Yanjie Xu; Zhumei Shi; Yingyi Wang; Junxia Zhang; Xirui Wang; Lei Cao; Hui Luo; Jiawei Chen; Ning Liu; Yongmei Yin; Yongping You
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 4.  Role of Bcl-2 family proteins and caspases in the regulation of apoptosis.

Authors:  Mohammad Shamsul Ola; Mohd Nawaz; Haseeb Ahsan
Journal:  Mol Cell Biochem       Date:  2011-01-06       Impact factor: 3.396

5.  hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing.

Authors:  Rachel Wilson Goehe; Jacqueline C Shultz; Charuta Murudkar; Sanja Usanovic; Nadia F Lamour; Davis H Massey; Lian Zhang; D Ross Camidge; Jerry W Shay; John D Minna; Charles E Chalfant
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

6.  Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis.

Authors:  Joseph George; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

Review 7.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  Baicalein-induced apoptosis via endoplasmic reticulum stress through elevations of reactive oxygen species and mitochondria dependent pathway in mouse-rat hybrid retina ganglion cells (N18).

Authors:  Yu-Ching Li; Hui-Ju Lin; Jen-Hung Yang; Jai-Sing Yang; Heng-Chien Ho; Shu-Jen Chang; Te-Chun Hsai; Hsu-Feng Lu; An-Cheng Huang; Jing-Gung Chung
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

9.  Caspase polymorphisms and genetic susceptibility to multiple myeloma.

Authors:  H Dean Hosgood; Dalsu Baris; Yawei Zhang; Yong Zhu; Tongzhang Zheng; Meredith Yeager; Robert Welch; Shelia Zahm; Stephen Chanock; Nathaniel Rothman; Qing Lan
Journal:  Hematol Oncol       Date:  2008-09       Impact factor: 5.271

10.  Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.

Authors:  Ji Qian; Hui-Qi Qu; Lixin Yang; Ming Yin; Qiming Wang; Shaohua Gu; Qihan Wu; Xueying Zhao; Wenting Wu; Junjie Wu; Xiaoming Tan; Wenqing Chen; Haijian Wang; Jiucun Wang; Weiwei Fan; Hongyan Chen; Baohui Han; Daru Lu; Qingyi Wei; Li Jin
Journal:  Oncologist       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.